Inatani, Shoko et al
"Preclinical metabolism and disposition of TP0473292, a novel oral prodrug of the potent metabotropic glutamate 2/3 receptor antagonist TP0178894 for the treatment of depression." Drug Metabolism and Disposition
(2023):
DMD-AR-2022-001116.
Web. 10 June. 2023.
